Contribution: Industrial Research Assistance Program – Contributions to Firms
Avivo Biomedical Inc.
$557,000.00
Improvement of a protein production platform for clinical use and the integration of B cleaving enzymes
FY 2023-24 · 2023-05-01
Summary
This project aims to further improve the A enzyme production platform for a final product for use all preclinical and subsequent clinical studies, as well as the integration of a new EnzBO1, a B antigen cleaving enzyme, into the enzyme production platform.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Vancouver|Vancouver, British Columbia, Canada
Recipient Type
For-profit organization
Business Number
706842473
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 0 | 2023-05-01 | 2023-24 | $497,000.00 |
| 4 | 2023-05-01 | 2023-24 | $497,000.00 |
| 5 | 2023-05-01 | 2023-24 | $557,000.00 |
As published
Additional Information
This agreement has been amended 1 time(s). The total amended value is 60,000 dollars.
Additional Information (French)
Cet accord a été modifié 1 fois La valeur totale des modifications est de 60 000 dollars.
Agreement End Date
2025-03-31
Agreement Number
1006507
Agreement Start Date
2023-05-01
Agreement Title
Improvement of a protein production platform for clinical use and the integration of B cleaving enzymes
Agreement Title (French)
Développement et gestion d’une architecture logicielle interne pour soutenir les itérations rapides d’une plateforme logicielle de conformité au marketing financier.
Agreement Type
Contribution
Agreement Value
$557,000.00
Amendment Date
2025-02-20
Amendment Number
5
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
This project aims to further improve the A enzyme production platform for a final product for use all preclinical and subsequent clinical studies, as well as the integration of a new EnzBO1, a B antigen cleaving enzyme, into the enzyme production platform.
Description (French)
Projet de développement logiciel visant à améliorer le développement et la gestion d’une architecture logicielle interne pour le produit de conformité marketing destiné aux institutions financières.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Vancouver Centre
Federal Riding (French)
Vancouver-Centre
Federal Riding Number
59034
NAICS Code
541710
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
706842473
Recipient City
Vancouver|Vancouver
Recipient Country
CA
Recipient Legal Name
Avivo Biomedical Inc.
Recipient Postal Code
V6E 4E5
Recipient Province or Territory
BC
Recipient Type
F
Reference Number
172-2023-2024-Q1-1006507
